Drug Shortage Report for JAMP HYDROXYCHLOROQUINE SULFATE
Report ID | 221982 |
Drug Identification Number | 02491427 |
Brand name | JAMP HYDROXYCHLOROQUINE SULFATE |
Common or Proper name | Hydroxychloroquine Sulfate Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | HYDROXYCHLOROQUINE SULFATE |
Strength(s) | 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | P01BA |
ATC description | ANTIMALARIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-27 |
Estimated end date | 2024-04-19 |
Actual end date | 2024-04-15 |
Shortage status | Resolved |
Updated date | 2024-04-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-04-17 | French | Compare |
v3 | 2024-04-17 | English | Compare |
v2 | 2024-03-12 | French | Compare |
v1 | 2024-03-12 | English | Compare |
Showing 1 to 4 of 4